Get a glimpse into our company and investor data—powered by the PitchBook Platform
AngelLATEST DEAL TYPE
$6MLATEST DEAL AMOUNT
Operator of a drug development company. The company specializes in pharmacotherapeutics and novel delivery models for developing therapeutics and drugs to improve the lives of patients suffering from rare and orphan diseases.